Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yumo, Du"'
Publikováno v:
Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100474- (2021)
Purpose: Hepatoid adenocarcinoma of the lung (HAL) is a rare form of lung cancer, which is characterized by its morphologic hepatoid features. The clinical characteristics and prognosis of this rare form of lung cancer remain obscure. Methods: The cl
Externí odkaz:
https://doaj.org/article/ec3ac339c87d4592a2faba35eeb7ec9b
Autor:
Yiqing, Li, Meng, Qiu, Boqi, Li, Jie, Xiao, Wenjuan, Yang, Shuangfeng, Xie, Yumo, Du, Kezhi, Huang, Danian, Nie
Publikováno v:
Translational Cancer Research. 11:2175-2184
T-cell lymphoma (TCL) has a very poor prognosis with limited treatment options and novel therapeutic target is urgently needed. Our previous studies have found that suppression of membrane-bound prostaglandin E2 synthase l/prostaglandin E2 (mPGES-1/P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9340ba4c3a9928d03906212c8adf3911
https://doi.org/10.21037/tcr-21-2834
https://doi.org/10.21037/tcr-21-2834
Publikováno v:
Pediatric bloodcancer. 70(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5687e29b8ea2316b4bcf984f3751ba0b
https://pubmed.ncbi.nlm.nih.gov/36069620
https://pubmed.ncbi.nlm.nih.gov/36069620
Autor:
Danian Nie, Xiaohui Xiao, Jiaoting Chen, Shuangfeng Xie, Jie Xiao, Wenjuan Yang, Hongyun Liu, Jieyu Wang, Liping Ma, Yumo Du, Kezhi Huang, Yiqing Li
Publikováno v:
Experimental cell research. 416(2)
T-cell lymphoma (TCL) is a highly heterogeneous group of invasive non-Hodgkin lymphoma with adverse prognosis and limited treatment options. The relationship between TCL and Exportin-1 (XPO1), a major nuclear export receptor, has not been established
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d10963aeec6cb79951050beb6df9bc
https://pubmed.ncbi.nlm.nih.gov/35489384
https://pubmed.ncbi.nlm.nih.gov/35489384
Publikováno v:
Cancer Treatment and Research Communications, Vol 29, Iss, Pp 100474-(2021)
Purpose Hepatoid adenocarcinoma of the lung (HAL) is a rare form of lung cancer, which is characterized by its morphologic hepatoid features. The clinical characteristics and prognosis of this rare form of lung cancer remain obscure. Methods The clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c6ce45b6562d5ad93b226fddcede250
https://pubmed.ncbi.nlm.nih.gov/34656923
https://pubmed.ncbi.nlm.nih.gov/34656923
Autor:
Yiqing Li, Ting Tang, Jie Xiao, Boqi Li, Wenjuan Yang, Shuangfeng Xie, Yumo Du, Kezhi Huang, Danian Nie
Publikováno v:
Annals of hematology. 101(7)
The optimal induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia (AML) are not well-defined since the lack of direct comparisons between emerging treatments. Network meta-analysis (NMA) is a statistical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed75003ff96790261d96a78587f573ed
https://pubmed.ncbi.nlm.nih.gov/35445843
https://pubmed.ncbi.nlm.nih.gov/35445843
Publikováno v:
Experimental Cell Research. 363:114-120
Mesenchymal stem cells (MSCs) and regulatory T cells (Tregs) are both potent immune-modulators. The aberrant proliferation and function of Tregs plays an important role in the development of asthma. Our previous studies have demonstrated the role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c741f4339c9b60943b96e233da66480d
https://doi.org/10.1016/j.yexcr.2017.12.021
https://doi.org/10.1016/j.yexcr.2017.12.021
Publikováno v:
Journal of Thoracic Disease. 9:655-665
The anti-PD-1/PD-L1 monoclonal antibody has showed promising results in various cancers via enhancing T cell functions. However, many questions remain in the role and safety in previously-treated, advanced non-small-cell lung cancer (NSCLC). Thus, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d18d983b32f05f81b60442a286a97e75
https://doi.org/10.21037/jtd.2017.03.104
https://doi.org/10.21037/jtd.2017.03.104
Autor:
Yongxun, Zhuansun, Yumo, Du, Fengting, Huang, Lin, Lin, Rui, Chen, Shanping, Jiang, Jianguo, Li
Publikováno v:
International immunopharmacology. 77
Exosomes derived from Mesenchymal Stem Cells (MSCs) possesses similar immunomodulatory effect as MSCs. It had been suggested that MSCs exosomes contain higher level of miR-1470 compared to exosomes derived from fibroblast. Here, we show that MSCs exo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cca2972c66c578d6c74f98f9aa19c602
https://pubmed.ncbi.nlm.nih.gov/31685437
https://pubmed.ncbi.nlm.nih.gov/31685437